Ayr Strategies Enters Arizona Market With $81 Million Acquisition

Ayr Strategies (CSE: AYR.A) has wasted no time expanding into the Arizona market following the decision last night by voters to make recreational cannabis legal within the state. The company this morning announced that it has agreed to acquire a vertically integrated operator for total upfront consideration of $81 million under a binding term sheet.

The asset, whom is unnamed, currently operates a 10,000 square foot cultivation and processing facility in Chandler, while also having an 80,000 square foot facility under construction in Phoenix. In terms of dispensaries, its slightly unclear in terms of what Ayr has acquired. Initially, the release indicates there are three licensed dispensaries, however it then goes on to say that that it is acquiring “three licensed dispensaries in greater Phoenix, two in Chandler and one in Glendale.”

Further, the asset is said to enable Ayr to “enter a thriving and robust market at 3.7x 2021 estimated Adjusted EBITDA, generating significant value for our shareholders.”

The upfront purchase price of $81 million will be settled via $10 million in cash, as well as $41 million in stock, which is estimated to result in the issuance of 2.75 million shares of the issuer. Additionally, $30 million in sellers notes will also be payable. Earn-out payments of up to 2.0 million shares are also in play, dependent upon certain cultivation targets for 2021 and 2022 being met.

“Arizona has been a terrific medical market, third in the U.S. in terms of patient penetration at 3.4% and currently generating approximately $800 million in annual revenue. Yesterday, voters decided to make it a recreational use market as well. We are thrilled to be able to leverage our experience, talent, brands and success in Nevada and Massachusetts to bring quality and choice to the Arizona market.”

Jonathan Sandelman, Chairman and Chief Executive Officer of Ayr

Following the transaction, which is subject to final due diligence, the company will have operations across Arizona, Massachusetts, Nevada, Pennsylvania, and Ohio.

Ayr Strategies last traded at $19.55 on the CSE.


Information for this briefing was found via Sedar and Ayr Strategies. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

First Phosphate Gains Danish State Support With LOI For EUR 170 Million Credit Guarantee

Denarius Metals Offers To Acquire Emerita At Just $0.30 A Share

Related News

Ayr Strategies Closes Overnight Marketed Offering, Raises $157.6 Million

Ayr Strategies (CSE: AYR.a) this morning closed its overnight marketed public offering. The financing, initially...

Thursday, January 14, 2021, 09:48:37 AM

Ayr Strategies: Canaccord Reiterates Rating Following Arizona Transaction

This week, Canaccord Genuity came out with a note reiterating their C$25 price target and...

Friday, November 6, 2020, 12:20:00 PM

Ayr Strategies: PI Financial Initiates With $60 Price Target, Buy Rating

On January 20th, PI Financial became the fourth firm to cover Ayr Strategies’ (CSE: AYR.a)....

Sunday, January 24, 2021, 11:34:00 AM

Ayr Strategies Announces Changing Of Name To Ayr Wellness

Ayr Strategies (CSE: AYR.a) this morning had a minor news release, wherein the firm announced...

Thursday, February 11, 2021, 09:11:45 AM

Ayr Strategies Offers Incentive On In-The-Money, Acceleration-Clause-Meeting Warrants

Ayr Strategies (CSE: AYR.A) this evening announced that it is offering a short term incentive...

Monday, November 23, 2020, 05:28:27 PM